Equivalent exposures can result in qualitatively or quantita tively dissimilar toxic effects across species, with the underlying molecular mechanisms being often not well defined. In many cases, differences in metabolic handling of the chemical (metabo lism and disposition) provide an explanation of these differences, but in other cases the explanation is less obvious. This variability in the outcome of toxicant exposures complicates the interspe cies extrapolation of human hazard from animal testing data. MicroRNAs (miRNAs) are a family of noncoding RNAs that post transcriptionally regulate the expression of their target genes that have fundamental roles in physiology, disease, and toxicological responses. Importantly, these noncoding genes are characterized by a high evolutionary flux, in terms of miRNA repertoire and functioning, even among closely related species. Furthermore, evi dence is emerging that the enzymes of drug metabolism are also under miRNA regulation and thus offer a new twist to an old para digm, whereby manipulation of the expression of these enzymes affects toxic outcomes. In this review, we discuss how miRNA may contribute to the interspecies variability observed in the response to toxicant exposures. Although few studies have so far specifically examined the contribution of differences in miRNA regulation to speciesdependent responses to toxicological exposures, we believe that this will be an area of intense research in the coming years.
In the past 10-15 years, the discovery of endogenous, evolutionary conserved, noncoding RNAs with important physiological functions has overturned the classic view of RNA as a passive intermediate of gene transcription. At present, three main classes of noncoding, regulatory RNA are known in animals: the piwi-interacting RNAs, the short interfering RNAs, and microRNAs (miRNAs) (Moazed, 2009) . Of these, the most extensively studied are miRNAs that direct the RNA-induced silencing complex to repress the expression of their target genes. miRNA genes are located either within protein-coding genes (30-40% of mammalian miRNAs) or within their own specified intergenic loci. The former are cotranscribed with their host genes, whereas the later have distinct promoters and regulatory elements (Carthew and Sontheimer, 2009) . The product of the transcription is a long RNA transcript, which is subsequently cleaved in a multistep process-involving among others the DICER and DROSHA enzymes-to generate the mature miRNA (Carthew and Sontheimer, 2009) . miRNAs negatively regulate their gene targets by repressing mRNA translation and/or inducing mRNA degradation, although the precise mechanisms are still being investigated and debated (Bartel, 2009; Carthew and Sontheimer, 2009; Eulalio et al., 2008; Filipowicz et al., 2008) . Bioinformatic analysis indicates that the majority of mammalian genes (~60%) are subject to miRNA regulation (Friedman et al., 2009 ). In addition, in silico and experimental data concur that a single miRNA can possibly regulate the levels of hundreds or thousands of genes (Baek et al., 2008; Grimson et al., 2007; Selbach et al., 2008) . As expected, given their prominent regulatory roles, miRNA expression is tightly regulated, being cell, tissue, and developmental stage dependent (Bartel, 2004) . Nevertheless, dysregulation of miRNAs has been linked to the initiation and development of numerous diseases including cancer, cardiovascular diseases, and central nervous system disorders (Taft et al., 2010) . However, this review will focus on a different issue: the possibility that miRNAs are a key factor in determining the differential response of species to toxic exposures.
SPECIES DIFFERENCES IN TOXICOLOGICAL RESPONSES
Animals are routinely used for the evaluation of potential human hazard associated with chemicals or other agents to which the public may be exposed. For example, the carcinogenic potencies of regulated chemicals are evaluated using the rodent lifetime bioassay (Butterworth et al., 1995; Weisburger and Williams, 1981) . The central concept behind the use of animals as laboratory experimental systems and for toxicity testing is the underlying similarity in fundamental biology between humans and these animals. Animal testing is necessarily followed by toxicological sciences 131(2), 337-342 2013 doi:10.1093/toxsci/kfs302 Advance Access publication October 22, 2012 an interspecies extrapolation in order to evaluate human risk. Nevertheless, fundamental differences in the intracellular regulatory machinery, biochemistry, and metabolism of humans and animals have accumulated due to natural selection or genetic drift, affecting toxicological responses and disease susceptibilities (Cunningham, 2002; Holsapple et al., 2006; Klaunig et al., 2003; Lake, 2009; Rangarajan and Weinberg, 2003; Rangarajan et al., 2004; Whysner and Williams, 1996) . A classic example of such a species difference in toxicological responses can be seen following exposure to d-limonene, which induces nephropathy in male rats but not in humans, in a mechanism involving the a2µ-globulin protein (Whysner and Williams, 1996) . The interaction of the chemical with the a2µ-globulin causes the accumulation of the protein in the kidney and subsequently cytotoxicity. In this specific case, the mechanistic reason behind the species difference has been determined to be the male rat-specific expression of a2µ-globulin (Whysner and Williams, 1996) . However, in most cases, the mechanistic bases for species-specific effects are less well defined. For example, peroxisome proliferator and phenobarbital-type chemicals are also acknowledged to have distinct species effects, causing liver tumors by nongenotoxic mechanisms in rodents, but epidemiological data indicate that they are not harmful to humans (Holsapple et al., 2006; Klaunig et al., 2003; Lake, 2009 ). The susceptibility of rodents to liver tumors following treatment with these chemicals is associated with a rodent-specific induction of hepatic proliferation, although it is not clear why humans are resistant to hepatocarcinogenicity induced by these chemicals (Holsapple et al., 2006; Klaunig et al., 2003) . In addition, there is probably another class of chemicals which may be falsely classified as human hazards based on animal data, when little or no epidemiological data are available. Finally, some toxicants which are harmful to humans may not be detected by animal testing due to human-specific effects.
Clearly, a greater understanding of the cellular and molecular differences between species would be of great help in the interpretation of data collected from animal assays. In the postgenomic era, there is considerable support for the notion that modifications in gene regulation is the primary force driving animal evolution, whereas the number and sequences of proteincoding genes are fairly consistent across animal genes (Carroll, 2005; Levine and Tjian, 2003; Taft et al., 2007) . Hence, it is probable that in most cases the molecular mechanisms associated with species-specific toxicological responses of animals are at the levels of gene regulation (e.g., change in gene expression patterns, regulatory elements in promoters and enhancer, intracellular networks, epigenetic regulation, and noncoding RNAs). Intriguingly, fascinating evidence links altered miRNA regulation to the evolution of animal diversity and complexity. Evolution of animal miRNAs is a highly dynamic and ongoing process, even among closely related species (Berezikov, 2011) , the rate of accumulation of new miRNAs during mammalian evolution was much higher than the respective for transcription factors (Chen and Rajewsky, 2007) . miRNAs are intrinsically highly evolvable molecules, as changes in a few nucleotides can have prominent functional effects (Chen and Rajewsky, 2007) ; there is a correlation between the number of miRNAs and increased diversity and complexity in vertebrates (Heimberg et al., 2008) .
Significantly, considerable evidence has also accumulated demonstrating the importance of miRNAs in the toxicological responses of organisms. We have recently reported that a wide range of chemical treatments affect liver miRNAs in a manner dependent on the time, dose, and mode of action of the chemicals (Koufaris et al., 2012) . This is in agreement with the general view that miRNAs are responsive to cell stress (reviewed in Lema and Cunningham, 2010) . Dysregulation of miRNAs following toxic insults is expected to have prominent effects on the adaptive and adverse responses of animals, as these genes are the master regulators of important toxicological responses such as cell proliferation, apoptosis, and differentiation (Bartel, 2004) and also affect the activity of drug-metabolizing and nuclear receptors (Yokoi and Nakajima, 2011) . Therefore, besides being prominent regulators of the cellular phenotype, including the toxicological responses, we also know that miRNAs are evolutionary dynamic genes. Coupling these observations together suggests that differences at the miRNA level could be crucial in explaining the observed interspecies variability in the response to toxicant exposures. Here, we will consider three distinct mechanisms by which miRNAs could, in theory, propagate such effects by altering the intracellular wiring of cells: differential regulation in response to toxic exposures, cross-species differences in miRNA:mRNA interactions, and the existence of lineage/species/strain-specific miRNA repertoires.
DIFFERENCES IN miRNA REGULATION BETWEEN SPECIES
Even though there is considerable evidence that miRNAs are affected by toxic exposures or cell stress (Lema and Cunningham, 2010) , few studies have compared directly the effects of toxic treatments across species. Importantly, these provide evidence that differential effects of the treatments on miRNA expression affect the outcome of the toxic exposure. Pogribny et al. (2010) compared the effect of a methyl-deficient diet (which induced a condition in mice similar to nonalcoholic steatohepatitis) on the hepatic miRNAome of a sensitive (C57BL/6J) and a more resistant (DBA/2J) mice strain. They reported that between the two strains the effects of the treatment on miRNAs varied both qualitative (i.e., miRNAs only deregulated in one strain) and quantitative (much more pronounced changes in the sensitive strain). Importantly, the differentially affected miRNAs were shown to be involved in the regulation of processes that are implicated in nonalcoholic steatohepatitis development, e.g., lipid metabolism, apoptosis, and methylation (Pogribny et al., 2010) . The authors of this study interpreted these results that the susceptibility of the two strains could be linked to their different miRNA profiles. A second intriguing study examined the effect of peroxisome proliferator treatment on the expression of mice liver miRNAs (Shah et al., 2007) . Long-term treatment with 338 KOUFARIS AND GOODERHAM such chemicals causes liver tumors in rodents via nongenotoxic mechanisms, involving an induction of hepatic proliferation, whereas there is no evidence of increased cancer risk in humans (Klaunig et al., 2003) . Treatment with the peroxisome proliferator chemical Wy-14,643 resulted in the activation of an miRNAsignaling cascade involving let-7c which drives hepatocellular proliferation (Shah et al., 2007) . Intriguingly, activation of this miRNA cascade, and the associated hepatocellular proliferation, was not observed in humanized mice in which their wildtype receptor for peroxisome proliferator chemicals has been replaced by the human homolog (Shah et al., 2007) . This study therefore suggests that differences in the regulation of an miRNA signaling cascade could be involved in the susceptibility of rodents to hepatocarcinogenicity following treatment with peroxisome proliferator chemicals.
Neither of the two studies mentioned above reporting differential effects of treatments on miRNAs of species/strains (Pogribny et al., 2010; Shah et al., 2007) had identified the mechanistic reason why the effects of the treatments on miRNA expression differed between the tested animals. At present, much remains to be learned regarding the regulation of miRNA expression and biogenesis (Krol et al., 2010) . The regulatory circuits of miRNAs are highly complex, often being complicated negative or positive feedback loops with one or more transcription factors. Nevertheless, evidence supports that the transcription of miRNA genes is regulated in the same manner as protein-coding genes, i.e. binding of transcription factors, DNA methylation, and histone modification being implicated, whereas regulation can also occur at the level of miRNA biogenesis (Krol et al., 2010) . Importantly, plausible mechanisms by which miRNA regulation may differ between species can be envisioned, e.g., changes in regulatory or enhancer elements associated with miRNA promoters or in the processing of the precursor RNA after transcription, although these will have to be proven experimentally.
DIFFERENCE IN miRNA:mRNA INTERACTIONS BETWEEN SPECIES
Fundamentally, the phenotypic effects of an miRNA are wholly determined by the set of proteins that they regulate. Given the widespread regulatory roles of miRNAs, the deregulation of a few or even a single miRNA:mRNA interaction could profoundly affect the phenotype of an organism. In support of this argument, several human single-nucleotide polymorphisms associated with an miRNA or miRNA-binding site in target mRNA have been linked to increased susceptibility to diseases (Ryan et al., 2010) . A cross-species shift in the targetome (miRNAs are predicted to have multiple targets) of an miRNA would therefore also alter the regulatory role of the miRNA. In animals, the set of miRNA target genes is determined by appreciable, but not complete, miRNA-mRNA sequence complementarity, which allows Watson-Crick pairing of the two nucleotide strands. Strong repression efficiency depends on the pairing of seven to eight nucleotide regions in the 3´UTR of mRNA to the "seed" region of the miRNAs (residues 2-8 on the 5´ end), and a number of other factors such as the number of miRNA:mRNA pairing sites, supplemental pairing outside the seed region, position of miRNA:mRNA pairing sites, and the presence of AU rich nucleotide sequences (Bartel, 2009; Grimson et al., 2007) . miRNA-mRNA pairings on 5´UTR or the coding regions of the mRNA can also induce posttranslational silencing, but are less effective (Baek et al., 2008 , Grimson et al., 2007 . Because there is an optimal level for protein expression (i.e., both too high and too low expressions may be harmful to the organisms), it is postulated that there is a coevolution of miRNA and their target mRNAs. In agreement with this, it was found that miRNAs can have adverse effects on an organism's health when expressed in a different species (Tang et al., 2010) .
An altered targetome would mean that an observed miRNA deregulation following toxic exposure or cell stress may result in different phenotypic consequences in different species. In theory, such a divergence in regulatory function of miRNAs between species could have occurred during evolution by (1) change in the mature miRNA sequence, especially the seed region (2) evolution of the mRNA target, especially the 3´UTR region (Berezikov, 2011) . Evolutionary divergence of the miRNA can occur by direct change in its sequence, altered processing during miRNA biogenesis, or altered RNA editing. Alternatively, the mRNA can gain or lose miRNA regulation by a change in its 3´UTR sequence or by altering the length of its 3´UTR. Importantly, changes in mature miRNA sequence would be expected to have significant cellular effects, as they would alter its targetome. Some proteins would no longer be subject to regulation by that miRNA, whereas new miRNAmRNA associations would occur. Indeed evidence shows that changes in the seed sequence of miRNAs occur mostly in less-expressed miRNAs, presumably because these are more tolerated by organisms (Liang and Li, 2009) . It would thus be expected that evolution of miRNA:mRNA regulation would most often progress by changes within the mRNA.
At present, the best example of a disruption of mRNA:miRNA interaction having a significant phenotypic consequence is that of Texel sheep. In these animals, which are characterized by pronounced muscularity, it was found that a single change in the 3´UTR of myostatin creates a novel binding site for mir1 and miR-206 miRNAs which are highly expressed in muscle, resulting in the repression of myostatin and promotion of muscular hypertrophy by causing depletion of that protein (Clop et al., 2006) . Another recent interesting study has reported that the progesterone receptor is subject to regulation by miR-96-an miRNA that we have shown to be induced in the rat liver after sustained treatment with several hepatotoxicants (Koufaris et al., 2012) -in primates but not in rodents, due to poorly conserved regions in the 3´UTR of the receptor (Liu et al., 2012) . It is therefore certainly a possibility that evolutionary changes in miRNA:mRNA targeting could affect toxic responses and evidence is starting to emerge supporting this model.
LINEAGE/SPECIES/STRAINSPECIFIC miRNA REPERTOIRE
A fascinating discovery of the last 5 years has been the deep conservation of miRNAs throughout animal evolution (Christodoulou et al., 2010; Grimson et al., 2008; Wheeler et al., 2009) . Once new miRNA genes are gained, they are very stable and are rarely lost during evolution (Grimson et al., 2008; Wheeler et al., 2009) . At the same time, new miRNAs are continually being acquired by evolving species (Grimson et al., 2008; Wheeler et al., 2009) . In fact, the rate of evolution of miRNAs is high enough that the miRNA repertoire differs even between closely related species and strains, e.g., sister nematode species (de Wit et al., 2009) , the human and chimpanzee brain (Berezikov et al., 2006) , and even rat strains (Linsen et al., 2010) . It appears that new miRNA genes can arise with such ease because they can emerge from a number of genomic sources, such as miRNA duplication, introns, pseudogenes, and transposable elements (Berezikov, 2011) . Due to this ease of generation, the rate of accumulation of new miRNAs during mammalian evolution was much higher than that for transcription factors (Chen and Rajewsky, 2007) .
At present, it is not clear how many of the lineage-species specific miRNAs have functional roles. However, given the widespread effects that miRNAs can have, if even a small minority of the species-specific are functional, then the miRNA milieu could be intricately involved in the intracellular wiring of regulatory networks and, ultimately, affecting an organism's response to toxic insult. Importantly, one study has associated species-specific miRNAs to toxicological outcomes (Mor et al., 2011) . This study found the activation of mouse-specific and rat-specific miRNAs in astrocytes (cells of the central nervous system that are important among other things in the bloodbrain barrier) following treatments with inflammation inducing lipopolysaccharide and interferon-γ and that these miRNAs regulate the tumor necrosis factor-α pathway. As more speciesspecific miRNAs are identified in the future, it is expected that additional relationships with toxic outcomes will be uncovered.
CONCLUSION
Over millions of years of evolution, species adapt to their specific environment and ecological niche. Animal diversity and complexity have been probably driven by changes at the level of gene regulation, with noncoding RNAs having prominent roles (Carroll, 2005; Levine and Tjian, 2003; Taft et al., 2007) . We are suggesting that species differences in miRNA regulation, function, and repertoire can act to attenuate or amplify the toxic effects on an organism of exogenous exposures (Fig. 1) . This hypothesis is in agreement both with the dynamic nature of miRNAs during animal evolution and with their important toxicological
FIG. 1.
Mechanisms by which miRNAs could contribute to species-specific toxicological responses. On the top panel, a species is shown in which treatment causes a toxic outcome, whereas in the lower panel a resistant species is shown. (A) In the first species, the compounds cause transcriptional induction of the conserved miRNA which subsequently promotes toxicity, whereas in the second species the compounds do not affect the expression of the miRNA. (B) The compound treatment induced the conserved miRNA in both species, but due to changes in miRNA sequence the miRNA no longer regulates the key protein. (C) The compound causes toxicity only in one species by affecting a species-specific miRNA.
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KOUFARIS AND GOODERHAM functions. However, at present, few studies have examined the contribution of miRNAs in the cross-animal variability of toxicological responses (Mor et al., 2011; Pogribny et al., 2010; Shah et al., 2007) . Importantly, tools are already available that can begin to address this lack of knowledge: (1) deep-sequencing can be used to identify differences in miRNA repertoire of animals displaying variable toxic outcomes, followed by bioinformatics and experimental approaches to elicit the biological roles of these miRNAs; (2) global miRNA profiling platforms can characterize miRNAs displaying different expression patterns after chemical exposures; (3) in silico tools can be used to identify evolutionary divergences in miRNA:mRNA interactions. In the future, a deeper understanding of these miRNA-related effects can potentially facilitate the interspecies extrapolation of animal testing, as well as the development of more suitable animal models. 
